Medication Adherence: The Final FrontierFebruary 13, 2013 Treatment of HIV has become so amazingly effective that when it fails, it's no overstatement to say that it's usually because the patient is not taking the medications. There are all kinds of provider-related reasons for this -- inadequate patient education, prescribing and dispensing errors, failure to address language or education deficits -- but here I want to focus on the patient-related causes. In other words, on non-adherence. (This used to be called "non-compliance." That term has become un-PC; for some reason non-adherence is viewed as nicer. Please explain.) Non-adherence in HIV care comes in a variety of flavors, including:
Read the rest of this article on TheBodyPRO.com, TheBody.com's sister site for health care professionals! Treatment of HIV has become so amazingly effective that when it fails, it's no overstatement to say that it's usually because the patient is not taking the medications. There are all kinds of provider-related reasons for this -- inadequate patient education, prescribing and dispensing errors, failure to address language or education deficits -- but here I want to focus on the patient-related causes. In other words, on non-adherence. (This used to be called "non-compliance." That term has become un-PC; for some reason non-adherence is viewed as nicer. Please explain.) Non-adherence in HIV care comes in a variety of flavors, including:
I'm sure there are others, but this list covers most of them. Note that these are not mutually exclusive, and some of the knottiest adherence problems come when more than one of the above is operative. Note also that I'm not counting the people who simply disappear from care -- the "engagement in care" or "linkage" issue -- which is a huge problem and responsible for lots of the drop-off in the infamous treatment cascade. But the multifactorial nature of poor adherence is one reason why studies of adherence interventions so often have negative results. How can any single intervention address all of these factors? Another reason for the negative studies is that the vast majority of patients do take their antivirals correctly -- and this good med-taking behavior is probably especially common among those with the wherewithal to sign an informed consent for a clinical study. Most of these folks don't need any help at all, so the intervention looks no better than the control; this study is an excellent example. Yet if we can't identify ahead of time the small fraction of our patients who will be non-adherent -- and study after study says we can't -- how can we target our interventions to the people who need them the most? (Next up: An Adherence Intervention that Actually Works -- But There's a Catch) Paul Sax is Clinical Director of Infectious Diseases at Brigham and Women's Hospital. His blog HIV and ID Observations is part of Journal Watch, where he is Editor-in-Chief of Journal Watch AIDS Clinical Care. This article was provided by Journal Watch. Journal Watch is a publication of the Massachusetts Medical Society.
Comment by: Wayne Stump
(Toronto, Ontario, Canada)
Fri., Feb. 22, 2013 at 12:14 am EST Dear Dr. Sax: Many thanks for your comments, as always. I had the pleasure of meeting you in person at the 2006 International AIDS Conference held in Toronto, Ontario, Canada, where I live. I have taken a great interest in the matter of medication adherence, particularly in the context of HIV infection, as a person living with HIV infection. I know the importance of adherence to antiretroviral medications because of the biological nature of HIV (its ability to mutate in the presence of moderate antiretroviral "pressure" (less than adequate adherence, or suboptimal antiretroviral regimens such as ZDV monotherapy) versus maximal antitretroviral pressure (as in what is possible with optimal adherence to today's effective antitretroviral medications). I was reminisciing with a friend about my first HIV antiretroviral regimen of zidovudine 500 mg per day (in 1991) taken in five 100 mg doses taken four hours apart, and the difficulty I found this when I was still working full-time, and even lost my dosette (it fell out of my pocket when I was climbing a telephone pole a telecommunications technician). I am amazed at the progess with the newer HIV antiretroviral meds (one pill, once a day, for example--unfortunately I'm still taking more than that number of pills twice a day, but nonetheless still very grateful for these medications!) I'm happy that in addition to studying the best new HIV antiretrovirals, physicians have also understood the human challenge of taking these with minimal error (either totally missed doses or delayed doses). Thank you for your continued interest in this challenge and please accept my very best wishes, Wayne Stump Toronto, Ontario, Canada
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before adding your comment, please read TheBody.com's Comment Policy.) |
|
|